| Year |
Citation |
Score |
| 2024 |
Dennys CN, Vermudez SAD, Deacon RJM, Sierra-Delgado JA, Rich K, Zhang X, Buch A, Weiss K, Moxley Y, Rajpal H, Espinoza FD, Powers S, Ávila AS, Gogliotti RG, Cogram P, et al. MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. e00376. PMID 38876822 DOI: 10.1016/j.neurot.2024.e00376 |
0.37 |
|
| 2024 |
Smith M, Dodis GE, Vanderplow AM, Gonzalez S, Rhee Y, Gogliotti RG. Potentiation of the M muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in mice. Biorxiv : the Preprint Server For Biology. PMID 38659804 DOI: 10.1101/2024.04.15.586099 |
0.693 |
|
| 2022 |
Cikowski J, Holt C, Arthur B, Smith M, Gonzalez S, Lindsley CW, Niswender CM, Gogliotti RG. Optimized Administration of the M PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mice. Acs Chemical Neuroscience. PMID 35671352 DOI: 10.1021/acschemneuro.2c00113 |
0.4 |
|
| 2022 |
Vermudez SAD, Buch A, Weiss K, Gogliotti RG, Niswender CM. Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome. Neuropharmacology. 209: 109022. PMID 35248529 DOI: 10.1016/j.neuropharm.2022.109022 |
0.309 |
|
| 2021 |
Vermudez SAD, Gogliotti RG, Arthur B, Buch A, Morales C, Moxley Y, Rajpal H, Conn PJ, Niswender CM. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model. Genes, Brain, and Behavior. PMID 34002468 DOI: 10.1111/gbb.12752 |
0.371 |
|
| 2021 |
Fisher NM, AlHashim A, Buch AB, Badivuku H, Samman MM, Weiss KM, Cestero GI, Does MD, Rook JM, Lindsley CW, Conn PJ, Gogliotti RG, Niswender CM. A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes. Jci Insight. PMID 33476302 DOI: 10.1172/jci.insight.143324 |
0.347 |
|
| 2020 |
Fisher NM, Gould RW, Gogliotti RG, McDonald AJ, Badivuku H, Chennareddy S, Buch AB, Moore AM, Jenkins MT, Robb WH, Lindsley CW, Jones CK, Conn PJ, Niswender CM. Phenotypic profiling of mGlu knockout mice reveals new implications for neurodevelopmental disorders. Genes, Brain, and Behavior. PMID 32248644 DOI: 10.1111/Gbb.12654 |
0.303 |
|
| 2018 |
Gogliotti R, Fisher N, Stansley B, Jones C, Lindsley C, Conn J, Niswender C. Total RNA-sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target. The Journal of Pharmacology and Experimental Therapeutics. PMID 29523700 DOI: 10.1124/Jpet.117.246991 |
0.371 |
|
| 2017 |
Fisher NM, Gogliotti RG, Vermudez SAD, Stansley BJ, Conn PJ, Niswender CM. Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome. Acs Chemical Neuroscience. PMID 29227625 DOI: 10.1021/acschemneuro.7b00414 |
0.324 |
|
| 2016 |
Gogliotti RG, Klar R, Rook JM, Ghoshal A, Zamorano R, Malosh C, Stauffer SR, Bridges TM, Bartolome JM, Daniels JS, Jones C, Lindsley CW, Conn PJ, Niswender CM. mGlu5 Positive Allosteric Modulation Normalizes Synaptic Plasticity Defects and Motor Phenotypes in a Mouse Model of Rett Syndrome. Human Molecular Genetics. PMID 26936821 DOI: 10.1093/Hmg/Ddw074 |
0.344 |
|
| 2013 |
Gogliotti RG, Cardona H, Singh J, Bail S, Emery C, Kuntz N, Jorgensen M, Durens M, Xia B, Barlow C, Heier CR, Plasterer HL, Jacques V, Kiledjian M, Jarecki J, et al. The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models. Human Molecular Genetics. 22: 4084-101. PMID 23736298 DOI: 10.1093/Hmg/Ddt258 |
0.744 |
|
| 2012 |
Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, Didonato CJ. Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 3818-29. PMID 22423102 DOI: 10.1523/Jneurosci.5775-11.2012 |
0.73 |
|
| 2011 |
Gogliotti RG, Lutz C, Jorgensen M, Huebsch K, Koh S, Didonato CJ. Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB/N mice. Neurobiology of Disease. 43: 142-51. PMID 21396450 DOI: 10.1016/j.nbd.2011.03.002 |
0.708 |
|
| 2010 |
Hammond SM, Gogliotti RG, Rao V, Beauvais A, Kothary R, DiDonato CJ. Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late. Plos One. 5: e15887. PMID 21249120 DOI: 10.1371/Journal.Pone.0015887 |
0.762 |
|
| 2010 |
Kular RK, Gogliotti RG, Opal P. Cpd-1 null mice display a subtle neurological phenotype. Plos One. 5. PMID 20844742 DOI: 10.1371/Journal.Pone.0012649 |
0.436 |
|
| 2010 |
Gogliotti RG, Hammond SM, Lutz C, Didonato CJ. Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy. Biochemical and Biophysical Research Communications. 391: 517-22. PMID 19961830 DOI: 10.1016/J.Bbrc.2009.11.090 |
0.755 |
|
| 2008 |
Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, DiDonato CJ, Monani UR, Morris GE, Burghes AH. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Human Molecular Genetics. 17: 1063-75. PMID 18178576 DOI: 10.1093/Hmg/Ddm379 |
0.76 |
|
| 2007 |
Heier CR, Gogliotti RG, DiDonato CJ. SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy? Journal of Child Neurology. 22: 1013-8. PMID 17761657 DOI: 10.1177/0883073807305669 |
0.694 |
|
| Show low-probability matches. |